"Supreme Court's Mifepristone Case: Implications for Abortion Lawsuits"

The Supreme Court is hearing a case brought by anti-abortion doctors challenging the FDA's regulatory actions on abortion pills, with potential implications for the entire drug approval process. The case questions the FDA's scientific expertise and the loosening of restrictions on mifepristone, the drug at the center of the case. Siding with the FDA are major medical associations and pharmaceutical companies, while the challengers argue that the FDA's changes are unjustified and unsafe. The case also involves a procedural hurdle regarding legal standing, and a decision is expected by summer.